Name of drug: Ampicillin

Dated ordered: july31 2019

Date Given: July 31, Aug 1 2019

Route: Intravenous

Dosage: 250mg 7/31/19

250mg 8/1/19

Frequency Q8

General action: inhibits cell wall synthesis during bacterial multiplication

Classification: Antibiotics

Indications: Respiratory tract infection

Soft tissue infection
Bacterial meningitis or septicemia

Client Response with actual side effects:

The patient did not manifest the side effects of the drugs such as nausea and vomitting

_______________________________________________________________________

Name of drug: Paracetamol

Date ordered: July 31,2019

Date given: July 31,Aug 1 ,2019

Route: Intravenous

Dosage 75mg 7/31/19

75mg 8/1/19

Frequency: Q4 PRN for fever

General Action: thought to produce analgesia by inhibiting prostaglandin and other substances
that sensitize pain receptors. Drug may relieve fever through central action in the hypothalamic
heat regulating center

Classification: Analgesics

Indications: Mild pain fever

Mild to moderate pain with adjunctive opioid analgesics;fever

Client response with actual side effects: the client’s body temperature from 37.5 to 36.5
the client did not manifest redness,nausea,vomiting

_____________________________________________________________________

Name of drug: Salbutamol ( brand) Albuterol ( Generic)

Date ordered: July 31,2019

Date given: July 31,2019, August 1

Route: Inhalation

Dosage: 2.5 mg 7/31/19

2.5mgv 8/1/19

Frequency: QID prn

General Action: It relaxes the smooth muscles of the bronchioles allowing maximum passage of
air. It decreases intracellular calcium which will relax the smooth muscles of the lungs by
mobilizing kinase through activation of cyclic-3’5’-adenosine monophosphate

Classification: Bronchodilators

Indication: Quick relief of bronchospasm induced through both exercise and physiological
alterations.

1. To control and prevent reversible airway obstruction caused by bronchial asthma,

chronic obstructive pulmonary diseases such as emphysema and chronic bronchitis

as well as other obstructive pulmonary diseases.
2. Inhalation: treatment of acute attacks of bronchospasm

Client response w/ side effects: the client rr decreases from 47 to 31 cpm

the client did not manifest nervousness,nausea and vomiting

____________________________________________________________________________
_
Name of Drug: Gentamicin

Date Ordered: 07/31/19

Date Given: 7/31/19, 8/1/19

Route: Intravenous

Dosage: 3mg 7/31/19

3mg 8/1/19

Frequency: q TID

General Action: inteferes w/ bacterial protein synthesis by binding to 30s and 50s ribosomal
subunits resulting in a defective bacterial cell membrane

Classification aminoglycoside antibiotics

Indication: Parenteral
- Serious infection caused by susceptible strains of pseudomonas aeruginosa, proteus
species, E coli, Klebsiella enterobacter Serratia species, Citrobacter, Staphylococcus
species
- Serious infection when causative organisms are not known
- Unlabeled use; with clindamycin as alternative regimen in PID

Client Response w/ side effects:

The client did not manifest

nausea,vomiting,stomach upset,loss of appetite, and injection site reactions
(pain, irritation, and redness).